SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-325446
Filing Date
2013-08-08
Accepted
2013-08-08 07:12:23
Documents
3
Period of Report
2013-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d578877d8k.htm 8-K 15358
2 EX-99.1 d578877dex991.htm EX-99.1 86926
3 GRAPHIC g578877logo.jpg GRAPHIC 11714
  Complete submission text file 0001193125-13-325446.txt   119988
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 131019878
SIC: 2834 Pharmaceutical Preparations